Emerging Markets Earnings Roundup: Abbott Laboratories, Novartis (Part 1)
This article was originally published in PharmAsia News
Executive Summary
Abbott and Novartis talk at length in quarterly earning calls on emerging markets as key to the fortunes of both companies. China again dominated the subject, but chief executives at both firms say the rapid pace of change in the country’s health sector remains a singular opportunity that means the only option is to double down on efforts to overcome regulatory and other hurdles.